中文
English
한국어
日本語
Español
Français
Русский
| 카탈로그 번호 | HV684016 |
|---|---|
| 설명 |
Vepsitamab (HV684016) is a research-grade recombinant antibody targeting CD3. Produced in mammalian cells with native-like glycosylation.
Highlights
|
| 종 반응성 | Human |
| 응용 분야 | ELISA, Bioactivity: FACS, Functional assay, Research in vivo |
| 숙주 종 | Human |
| 클론성 | Monoclonal |
| 이소타입 | (scFv-heavy-lambda)-(scFv-heavy-lambda)-scFc |
| 발현 시스템 | Mammalian cells |
| 타겟 | MUC-3, MUC-17, MUC17, Small intestinal mucin-3, Mucin-17, MUC3, T3E, T-cell surface antigen T3/Leu-4 epsilon chain, CD3e, CD3E, T-cell surface glycoprotein CD3 epsilon chain |
| 내독소 수준 | < 10 EU/mg |
| 순도 | >95% purity as determined by SDS-PAGE. |
| 정제 | Protein A/G purified from cell culture supernatant. |
| 등록번호 | Q685J3 & P07766 |
| 형태 | Liquid |
| 저장 완충액 | 0.01M PBS pH 7.4 데이터시트 인쇄본 또는 로트별 COA에 기재된 구체적인 완충액 정보를 참조하세요. |
| 안정성 및 저장 | Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt. |
| 대체 이름 | Bispecific, AMG199, AMG-199, AMG1992413453-53-7 |
| 배경 | Vepsitamab (AMG 199) is an anti-MUC17/CD3 BiTE antibody that binds to CD3 on T cells and MUC17 expressed on tumor cells, mediates redirected tumor cell lysis, and induces T cell activation and proliferation. |
| 참고사항 | For research use only. Not suitable for clinical or therapeutic use. |
| Isotype Control | Human IgG1 Recombinant Isotype Control Antibody (13R4) (HV080507) Human IgG1 (E356D/M358L), kappa Recombinant Isotype Control Antibody (HyHEL-10) (HV080013) Anti-LASV GPC Recombinant Antibody (Fab 37.7) (VK453013) |
Detects Recombinant Human MUC17 Protein, N-His (Cat No.: HV684012) in indirect ELISA.
Western blot analysis was performed using anti-human MUC17 monoclonal antibody at 1ug/mL on various samples.
Lane 1: recombinant human MUC17 (Catalog No: HV684012)
Lane 2: negative control
SDS-PAGE for Research Grade Vepsitamab
+86-027-65523339
중국 우한시 심둔사로 666번지 C동, 우한, 430206
